These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 6437931
1. Ascorbic acid status in thalassemia major. Tagliabue A, Turconi G, Allegrini M, De Stefano P, Borgna-Pignatti C, Bongo I, Dezza L, Cazzola M. Haematologica; 1984; 69(5):542-8. PubMed ID: 6437931 [No Abstract] [Full Text] [Related]
2. Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid. Peterson CM, Graziano JH, Grady RW, Jones RL, Markenson A, Lavi U, Canale V, Gray GF, Cerami A, Miller DR. Exp Hematol; 1979 Feb; 7(2):74-80. PubMed ID: 371974 [Abstract] [Full Text] [Related]
5. Scurvy and altered iron stores in thalassemia major. Cohen A, Cohen IJ, Schwartz E. N Engl J Med; 1981 Jan 15; 304(3):158-60. PubMed ID: 7442735 [No Abstract] [Full Text] [Related]
6. Oral ascorbic acid and iron excretion in thalassemic children treated with desferrioxamine-methansulfonate (Desferal). Hathirat P, Isarangkura P, Areekul S, Pleehachinda R, Tuntawiroon M. Birth Defects Orig Artic Ser; 1988 Jan 15; 23(5B):129-33. PubMed ID: 3390535 [No Abstract] [Full Text] [Related]
7. Vitamin C and iron. Nienhuis AW. N Engl J Med; 1981 Jan 15; 304(3):170-1. PubMed ID: 7442737 [No Abstract] [Full Text] [Related]
8. [Vitamin C in children with trisomy 21]. Colombo ML, Girardo E, Incarbone E, Conti R, Ricci BM, Maina D. Minerva Pediatr; 1989 Apr 15; 41(4):189-92. PubMed ID: 2528054 [Abstract] [Full Text] [Related]
9. Iron excretion in thalassemia after the administration of chelating agents. Markum AH, Iskandar W, Keng KL, Odang O. Paediatr Indones; 1969 Apr 15; 9(3):89-98. PubMed ID: 4981722 [No Abstract] [Full Text] [Related]
10. Ascorbic acid and iron excretion in a thalassemic child. Hathirat P, Areekul S, Pleehachinda R, Tuntawiroon M. Southeast Asian J Trop Med Public Health; 1983 Jun 15; 14(2):274. PubMed ID: 6635769 [No Abstract] [Full Text] [Related]
11. The iron status of children with low leucocyte ascorbic acid levels. Dawson KP, Downey DJ. N Z Med J; 1977 Nov 23; 86(600):479-80. PubMed ID: 272559 [Abstract] [Full Text] [Related]
13. Defective vitamin D metabolism in thalassemia major. Zaino EC, Yeh JK, Aloia J. Ann N Y Acad Sci; 1985 Nov 23; 445():127-34. PubMed ID: 3874574 [No Abstract] [Full Text] [Related]
14. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents]. Esposito L, Ferrara M, Ponte G. Pediatria (Napoli); 1981 Sep 30; 89(3):479-92. PubMed ID: 7346759 [No Abstract] [Full Text] [Related]
17. [Degree of vitamin C, PP and B 6 supply and requirements in patients with chronic pneumonia]. Podorozhnyi PG, Levkovskaia NI. Ter Arkh; 1973 Mar 30; 45(3):93-5. PubMed ID: 4268529 [No Abstract] [Full Text] [Related]
18. The effect of treatment with long-term chelating agents on iron overload in thalassaemia. Letsky EA, Flynn DM, Barry M. Br J Haematol; 1973 Aug 30; 25(2):285. PubMed ID: 4726921 [No Abstract] [Full Text] [Related]
19. New treatment for patients with iron overload. Griffith P, Burks J. J Nurs Care; 1978 Sep 30; 11(9):12-4. PubMed ID: 308223 [No Abstract] [Full Text] [Related]
20. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography. Flynn DM, Hoffbrand AV, Politis D. Birth Defects Orig Artic Ser; 1982 Sep 30; 18(7):347-53. PubMed ID: 6819017 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]